Center for Immunology-Center for Vertebrate Genomics trainee-led Symposium on Friday, May 15 | Cornell Center for Immunology

The Center for Immunology will be partnering with Center for Vertebrate Genomics to co-host a trainee-led Symposium on Friday, May 15, which will feature: - a faculty keynote - several trainee talks - a poster session The growing power of genome-wide computational approaches to understand complex immune processes makes this joint symposium very timely. There will be prizes for best trainee speake…

The Cornell Center for Immunology invites applications for funding to pursue multidisciplinary research projects in Immunology for up to $40,000. Proposals are due at 5:00 pm on January 14, 2026, and awards will be announced at the end of February 2026. Support for this grant mechanism is provided by the Cornell Center for Immunology and the Office of the Vice President for Research. Learn more h…

Smolka, a biochemist and former interim director of the Weill Institute for Cell and Molecular Biology, will support life sciences across the university. His two-year appointment began May 1. Smolka succeeds Hector Aguilar-Carreño, professor in the Department of Microbiology and Immunology in the College of Veterinary Medicine, who served in the role from July 2024 through April 2025.

Three innovative approaches to treating infections, fighting cancer, and enhancing the body’s immune system have been selected for funding through the Cornell Center for Immunology’s 2025 Multidisciplinary Seed Grants. Three innovative approaches to treating infections, fighting cancer, and enhancing the body’s immune system have been selected for funding through the Cornell Center for Immunology…

HomeNewsCOVID-flu vaccine could provide broad, lasting protection COVID-flu vaccine could provide broad, lasting protection The new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine.

HomeNewsNew appointments to bolster research and innovation New appointments to bolster research and innovation Krystyn J. Van Vliet has been named vice president for innovation and external engagement strategy, and Gary Koretzky ’78 will serve as interim vice provost for research.

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

HomeNewsTraining ‘immuno-engineers’ is goal of NIH grant Training ‘immuno-engineers’ is goal of NIH grant A new Cornell program will train graduate students interested in specializing in “immuno-engineering,” an emerging hybrid field that combines engineering and immunology.

Cornell researchers will use a five-year, $3.4 million grant from the National Institutes of Health to investigate whether chemical inhibitors of epigenetic regulation – including many FDA-approved drugs – could be re-purposed to treat HIV-1 infections that are persistent in tissues and represent the biggest challenge for a cure.

Dr. Hector Aguilar-Carreño, professor of virology in the Department of Microbiology and Immunology, was chosen for this fellowship due to his demonstrated success in and bright potential for leadership. He is among only nine fellows across the entire SUNY system and Cornell’s sole representative in the program.

Li Gan studies how abnormal proteins and the body’s immune system drive Alzheimer’s disease. Read the full story here.

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators. Read the full story here.

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine. Read the full story here.

New study finds that dietary inulin fiber alters the metabolism of certain gut bacteria, which in turn triggers what scientists call type 2 inflammation in the gut and lungs. Read the full story here.

A new study suggests that a unique set of regulatory networks controlled by neurons in the gut may be viable targets for future drug therapies to combat chronic inflammatory diseases including asthma, allergy and inflammatory bowel disease. Read the full story here.

“A whole new approach”: Neurons that sense pain protects the gut from inflammation and associated tissue damage by regulating the microbial community living in the intestines, according to a study from Weill Cornell researchers. Read the full story here.

Rocky An ’23 proposes a theory that could solve the decades-old mystery of why astronauts’ immune systems become suppressed in space. Read the full story here.

Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine. Read the full story here.

Small proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study. Read the full story here.

The center, with more than 120 faculty members, builds on the multidisciplinary nature of research into the immune system, with links between infection biology, vaccine development, genetics, genomics, malignancy and biomedical engineering. Read the full story here.